Editorial: Meningioma: From Basic Research to Clinical Translational Study.
作者信息
Ho Allen, Tang Hailiang
机构信息
Department of Neurosurgery, Stanford University School of Medicine, San Francisco, CA, United States.
Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
出版信息
Front Oncol. 2021 Oct 22;11:750690. doi: 10.3389/fonc.2021.750690. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Meningioma: From Basic Research to Clinical Translational Study.社论：脑膜瘤：从基础研究到临床转化研究
Front Oncol. 2021 Oct 22;11:750690. doi: 10.3389/fonc.2021.750690. eCollection 2021.
2
Editorial: Meningioma: From basic research to clinical translational study, volume II.社论：脑膜瘤：从基础研究到临床转化研究，第二卷。
Front Oncol. 2023 Mar 27;13:1150514. doi: 10.3389/fonc.2023.1150514. eCollection 2023.
3
Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.确定辅助放疗在脑膜瘤治疗中的作用：一项监测、流行病学和最终结果分析。
Neurosurg Focus. 2019 Jun 1;46(6):E3. doi: 10.3171/2019.3.FOCUS1971.
4
Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma.辅助放疗可改善颅内非典型脑膜瘤患者的无进展生存期。
Radiat Oncol. 2019 Sep 2;14(1):160. doi: 10.1186/s13014-019-1368-z.
5
The role of chemotherapy and targeted therapy in the treatment of intracranial meningioma.化疗和靶向治疗在颅内脑膜瘤治疗中的作用。
Curr Opin Oncol. 2012 Nov;24(6):666-71. doi: 10.1097/CCO.0b013e328356364d.
6
Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy.非典型脑膜瘤：161 例在我院接受手术与手术加放疗治疗患者的无进展生存期。
J Neurooncol. 2018 Jan;136(1):147-154. doi: 10.1007/s11060-017-2634-2. Epub 2017 Oct 28.
7
Early postoperative radiotherapy improves progression free survival in patients with grade 2 meningioma.早期术后放疗可改善 2 级脑膜瘤患者的无进展生存期。
Acta Neurochir (Wien). 2013 Aug;155(8):1385-90; discussion 1390. doi: 10.1007/s00701-013-1775-0. Epub 2013 Jun 1.
8
Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.恶性脑膜瘤：初始积极手术及辅助放疗的指征。
J Neurooncol. 1998 Apr;37(2):177-88. doi: 10.1023/a:1005853720926.
9
Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningioma.基于危险度分级的颅底脑膜瘤（WHO 分级 I 级和 II 级）辅助放疗。
J Cancer Res Clin Oncol. 2019 May;145(5):1351-1360. doi: 10.1007/s00432-019-02891-6. Epub 2019 Apr 5.
10
Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma.立体定向放射治疗作为颅内二级和三级脑膜瘤的原发确定性或术后治疗，比复发性脑膜瘤的立体定向放射治疗更能控制疾病。
J Neurooncol. 2017 Sep;134(2):407-416. doi: 10.1007/s11060-017-2540-7. Epub 2017 Jun 30.
引用本文的文献
1
Case report: Unilateral paralysis of the hypoglossal nerve as the only clinical sign of clivus meningioma - a case report and literature review.病例报告：舌下神经单侧麻痹作为斜坡脑膜瘤的唯一临床体征——病例报告及文献综述
Front Oncol. 2024 Jan 24;14:1337680. doi: 10.3389/fonc.2024.1337680. eCollection 2024.
2
Editorial: Meningioma: From basic research to clinical translational study, volume II.社论：脑膜瘤：从基础研究到临床转化研究，第二卷。
Front Oncol. 2023 Mar 27;13:1150514. doi: 10.3389/fonc.2023.1150514. eCollection 2023.
3
Bone Invasive Meningioma: Recent Advances and Therapeutic Perspectives.骨侵袭性脑膜瘤：最新进展与治疗前景
Front Oncol. 2022 Jun 30;12:895374. doi: 10.3389/fonc.2022.895374. eCollection 2022.
本文引用的文献
1
A clinically applicable integrative molecular classification of meningiomas.一种具有临床应用价值的脑膜瘤综合分子分类方法。
Nature. 2021 Sep;597(7874):119-125. doi: 10.1038/s41586-021-03850-3. Epub 2021 Aug 25.
2
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.2021 年世卫组织中枢神经系统肿瘤分类：概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
3
Advances in meningioma genomics, proteomics, and epigenetics: insights into biomarker identification and targeted therapies.脑膜瘤基因组学、蛋白质组学和表观遗传学的进展：对生物标志物识别和靶向治疗的见解。
Oncotarget. 2020 Dec 8;11(49):4544-4553. doi: 10.18632/oncotarget.27841.
4
Meningiomas from a developmental perspective: exploring the crossroads between meningeal embryology and tumorigenesis.从发育角度看脑膜瘤：探索脑膜胚胎学与肿瘤发生学的交叉点。
Acta Neurochir (Wien). 2021 Jan;163(1):57-66. doi: 10.1007/s00701-020-04650-w. Epub 2020 Nov 20.
5
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma.辅助放疗对非典型性和间变性脑膜瘤的疗效。
Cancer Med. 2019 Jan;8(1):13-20. doi: 10.1002/cam4.1531.
6
Management of meningioma.脑膜瘤的管理
Presse Med. 2018 Nov-Dec;47(11-12 Pt 2):e245-e252. doi: 10.1016/j.lpm.2018.05.016. Epub 2018 Nov 16.
7
Advances in meningioma genetics: novel therapeutic opportunities.脑膜瘤遗传学的进展：新的治疗机会。
Nat Rev Neurol. 2018 Feb;14(2):106-115. doi: 10.1038/nrneurol.2017.168. Epub 2018 Jan 5.
8
Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.WHO 三级脑膜瘤中雌激素受体的预后价值：来自单一机构的长期随访研究。
J Neurosurg. 2018 Jun;128(6):1698-1706. doi: 10.3171/2017.2.JNS162566. Epub 2017 Aug 18.
9
KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas.KLF4 在间变性脑膜瘤干细胞和人脑膜瘤中是一种肿瘤抑制因子。
J Mol Cell Biol. 2017 Aug 1;9(4):315-324. doi: 10.1093/jmcb/mjx023.
10
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.基于 DNA 甲基化的脑膜瘤分类和分级系统：一项多中心回顾性分析。
Lancet Oncol. 2017 May;18(5):682-694. doi: 10.1016/S1470-2045(17)30155-9. Epub 2017 Mar 15.
Zotero 插件